Fulcrum reports ~$352.3M cash as of Dec 31, 2025; updates presentation for JPM conference

Fulcrum Therapeutics, Inc.

Preliminary unaudited cash, cash equivalents and marketable securities of $352.3M as of December 31, 2025.
Updated corporate slide presentation (Exhibit 99.1) issued January 12, 2026, containing business and strategic updates.
Management to present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 7:30 a.m. PT.
Presentation will be webcast live on Fulcrum's investor relations website.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.